
Illumina, Inc.
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. The innovative products that we provide are facilitating breakthroughs in many scientific areas, including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and beyond. The progress we see being made in genomics inspires us to push the boundaries of what is possible so we can create the next generation of genomics solutions.
Latest Content

Medical Device Innovation Consortium Partners With PerkinElmer's Horizon Discovery To Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics

Addressing RNA Research Challenges

Agricultural Grant To Help Breed More Resilient Yams in West Africa

Beckman Coulter Life Sciences Accelerates Next Generation Sequencing by Launching the Biomek NGeniuS Next Generation Library Prep System

How Automation Can Help Avoid Next Generation Sequencing Errors Amid “The Great Resignation”

New Approach to Large-Scale Single-Cell Profiling Developed

Isolation of High Purity Exosomes

TATAA Biocenter Partners With Olink To Add High Quality Proteomics With Unrivaled Throughput to Their Multiomics Offering

Genetic Study of Over 57,000 People Provides Insights Into Severe COVID-19
